Baader Bank Aktiengesellschaft
BankPosition in NBIX — Neurocrine Biosciences Inc
CIK 1542629
Unterschleissheim, 2M
Position in NBIX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$421,350
-$213,082 QoQ
Shares Held
2,500
-45.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#505
of 768 holders
Holding Since
Dec 2022
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Baader Bank Aktiengesellschaft holds $6,167,549 across 10 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
47,204 | $3,392,079 | |
| 2 | CRON |
Cronos Group Inc.
|
200,000 | $556,000 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
2,500 | $421,350 | |
| 4 | LQDA |
Liquidia Corp
|
5,000 | $398,650 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
3,000 | $332,820 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
5,000 | $319,750 | |
| 7 | CGC |
Canopy Growth Corp
|
270,000 | $256,500 | |
| 8 | OGI |
Organigram Global Inc.
|
250,000 | $255,000 |
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $421,350 | 2,500 | Shares | Sole | 2026-07-23 | |
| 2024-03-31 | $634,432 | 4,600 | Shares | Sole | 2024-05-03 | |
| 2022-12-31 | $203,048 | 1,700 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||